Immutep Limited Gains 40.77%

Tue 14 Apr 20 at 05:30 PM
Immutep Limited Gains 40.77%

Immutep Limited (IMMP:NASDAQ) soared at $1.08, representing a gain of 40.8%. On Mon 13 Apr 20, IMMP:NASDAQ touched a New 2-Week High of $0.77. The stock appeared on our News Catalysts scanner on Wed 08 Apr 20 at 08:55 AM in the 'BIOTECH' category. From Mon 30 Mar 20, the stock recorded 44.44% Up Days and 50.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Immutep Limited (IMMP:NASDAQ)

Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.